Cargando…

Vaccination strategies for Korean patients with inflammatory bowel disease

Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoo Jin, Kim, Eun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449215/
https://www.ncbi.nlm.nih.gov/pubmed/35934888
http://dx.doi.org/10.3904/kjim.2022.149
_version_ 1784784244452622336
author Lee, Yoo Jin
Kim, Eun Soo
author_facet Lee, Yoo Jin
Kim, Eun Soo
author_sort Lee, Yoo Jin
collection PubMed
description Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD.
format Online
Article
Text
id pubmed-9449215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-94492152022-09-14 Vaccination strategies for Korean patients with inflammatory bowel disease Lee, Yoo Jin Kim, Eun Soo Korean J Intern Med Review Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD. Korean Association of Internal Medicine 2022-09 2022-08-08 /pmc/articles/PMC9449215/ /pubmed/35934888 http://dx.doi.org/10.3904/kjim.2022.149 Text en Copyright © 2022 The Korean Association of Internal Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Lee, Yoo Jin
Kim, Eun Soo
Vaccination strategies for Korean patients with inflammatory bowel disease
title Vaccination strategies for Korean patients with inflammatory bowel disease
title_full Vaccination strategies for Korean patients with inflammatory bowel disease
title_fullStr Vaccination strategies for Korean patients with inflammatory bowel disease
title_full_unstemmed Vaccination strategies for Korean patients with inflammatory bowel disease
title_short Vaccination strategies for Korean patients with inflammatory bowel disease
title_sort vaccination strategies for korean patients with inflammatory bowel disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449215/
https://www.ncbi.nlm.nih.gov/pubmed/35934888
http://dx.doi.org/10.3904/kjim.2022.149
work_keys_str_mv AT leeyoojin vaccinationstrategiesforkoreanpatientswithinflammatoryboweldisease
AT kimeunsoo vaccinationstrategiesforkoreanpatientswithinflammatoryboweldisease